{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-26-001312","form_type":"8-K","ticker":"SBEV","cik":"0001553788","company_name":"SPLASH BEVERAGE GROUP, INC.","filed_at":"2026-10-05T20:02:20+00:00","discovered_at":"2026-10-05T20:03:00.275641+00:00","generated_at":"2026-10-12T14:49:11.772810+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Endovia's CannEpil for canine bone cancer pain gets FDA 'minor use' status, opening conditional approval path","bullets":["FDA's Center for Veterinary Medicine determined CannEpil, an investigational CBD/THC oral solution for pain from bone cancer in dogs, qualifies as a 'minor use' under the MUMS program.","The determination makes CannEpil eligible for the conditional approval pathway, and FDA said the minor-use status will be maintained through approval of the New Animal Drug Application (NADA).","Endovia and Lupvindol BioSciences are scheduled to meet FDA on November 19, 2026 for a Pre-Submission Conference on required studies, manufacturing and regulatory submissions.","The companies are finalizing U.S.-based FDA-compliant manufacturing to support a potential 2027 veterinary commercial launch; CannEpil remains an unapproved investigational new animal drug."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-001312","json":"https://secwatch.observer/filing/0001731122-26-001312.json","markdown":"https://secwatch.observer/filing/0001731122-26-001312.md","text":"https://secwatch.observer/filing/0001731122-26-001312.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226001312/0001731122-26-001312-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226001312/e7991_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T14:49:11.772810+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}